gateway

Saturday, 28 March 2026 09:01

Vivobarefoot expands US presence with SoHo flagship

Rate this item
(0 votes)
 

British footwear pioneer Vivobarefoot is set to open its first US flagship store in June 2026, situated at 248 Lafayette Street in New York City’s SoHo district.

Spanning 1,500 sq ft, the retail hub marks a critical phase in the brand’s global strategy, following the recent establishment of its regional American headquarters in Austin, Texas. This move targets the city's high-density pedestrian traffic to capitalize on a growing domestic demand for minimalist footwear. According to industry data, the global barefoot shoe market is projected to reach $490.89 million in 2026, with North America maintaining the largest market share. The SoHo location will transition from a traditional point-of-sale to a high-touch service center, offering foot scanning, movement analysis, and one-on-one natural movement coaching.

Leveraging circularity and data to mitigate supply volatility

Central to the New York launch is a ‘nature-led’ retail concept that integrates the brand’s ReVivo reconditioning program and a preview of its VivoBiome 3D-printed, made-to-measure footwear innovation. This focus on localized, on-demand manufacturing serves as a strategic buffer against global supply chain volatility and the 19 per cent median return rate typical of online footwear sales. Financially, Vivobarefoot reported a US$168 million revenue in 2025, achieving an 85 per cent sales growth over the last four years supported by over £16 million in government-backed finance. Galahad Clark, Co-founder and CEO notes, New York serves as the perfect epicenter for their mission to ‘reconnect people to their natural potential,’ particularly as the brand navigates rising procurement costs by scaling sustainable, durable materials and circular business models.

Regenerative footwear and circular innovation

Founded in 2012 by Galahad and Asher Clark, Vivobarefoot specializes in minimalist footwear designed to restore natural foot function. With a Certified B Corp status and a 2025 revenue of US$168 million, the brand targets a ‘nature-first’ model. Key growth plans include expanding its US footprint and scaling the VivoBiome 3D-printing platform to achieve fully circular, zero-waste manufacturing.